In the high-stakes world of global health and safety, an invisible arms race is underway. As clandestine chemists develop novel psychoactive substances (NPSs) at a breakneck pace, the multi-billion dollar drug testing industry is being forced to innovate like never before. This dynamic is no longer just a law enforcement issue; it has become a […]
Continue Reading